The Optispan Podcast with Matt Kaeberlein cover image

Supplement Industry Secrets: What They Aren't Telling You About NAD+ & NMN | 39 - George Sutphin

The Optispan Podcast with Matt Kaeberlein

00:00

Insights on NMN Dosing, FDA Regulations, and Future Research Directions

This chapter explores recent findings on NMN dosing, highlighting the impact of FDA regulations on its supplement status. The discussion also emphasizes the necessity for future clinical trials to account for factors like age and kidney function, while critiquing the quality of existing research.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app